Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction

Kenya Honda, Yusuke Ohba, Hideyuki Yanai, Hideo Hegishi, Tatsuaki Mizutani, Akinori Takaoka, Choji Taya, Tadatsugu Taniguchi

Research output: Contribution to journalArticle

646 Citations (Scopus)

Abstract

Robust type-I interferon (IFN-α/β) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity1-6. It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88 (ref. 7). How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88-IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88-IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)3,4,8-11, is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88-IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B) 3,4,8-12. Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.

Original languageEnglish
Pages (from-to)1035-1040
Number of pages6
JournalNature
Volume434
Issue number7036
DOIs
Publication statusPublished - 2005 Apr 21
Externally publishedYes

Fingerprint

Interferon Type I
Toll-Like Receptor 9
Dendritic Cells
Oligodeoxyribonucleotides
Interferon Regulatory Factor-7
Ligands
Lipids

ASJC Scopus subject areas

  • General

Cite this

Honda, K., Ohba, Y., Yanai, H., Hegishi, H., Mizutani, T., Takaoka, A., ... Taniguchi, T. (2005). Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature, 434(7036), 1035-1040. https://doi.org/10.1038/nature03547

Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. / Honda, Kenya; Ohba, Yusuke; Yanai, Hideyuki; Hegishi, Hideo; Mizutani, Tatsuaki; Takaoka, Akinori; Taya, Choji; Taniguchi, Tadatsugu.

In: Nature, Vol. 434, No. 7036, 21.04.2005, p. 1035-1040.

Research output: Contribution to journalArticle

Honda, K, Ohba, Y, Yanai, H, Hegishi, H, Mizutani, T, Takaoka, A, Taya, C & Taniguchi, T 2005, 'Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction', Nature, vol. 434, no. 7036, pp. 1035-1040. https://doi.org/10.1038/nature03547
Honda K, Ohba Y, Yanai H, Hegishi H, Mizutani T, Takaoka A et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 2005 Apr 21;434(7036):1035-1040. https://doi.org/10.1038/nature03547
Honda, Kenya ; Ohba, Yusuke ; Yanai, Hideyuki ; Hegishi, Hideo ; Mizutani, Tatsuaki ; Takaoka, Akinori ; Taya, Choji ; Taniguchi, Tadatsugu. / Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. In: Nature. 2005 ; Vol. 434, No. 7036. pp. 1035-1040.
@article{3b1f6b22238541f4aa66965a69d927c2,
title = "Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction",
abstract = "Robust type-I interferon (IFN-α/β) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity1-6. It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88 (ref. 7). How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88-IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88-IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)3,4,8-11, is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88-IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B) 3,4,8-12. Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.",
author = "Kenya Honda and Yusuke Ohba and Hideyuki Yanai and Hideo Hegishi and Tatsuaki Mizutani and Akinori Takaoka and Choji Taya and Tadatsugu Taniguchi",
year = "2005",
month = "4",
day = "21",
doi = "10.1038/nature03547",
language = "English",
volume = "434",
pages = "1035--1040",
journal = "Nature Cell Biology",
issn = "1465-7392",
publisher = "Nature Publishing Group",
number = "7036",

}

TY - JOUR

T1 - Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction

AU - Honda, Kenya

AU - Ohba, Yusuke

AU - Yanai, Hideyuki

AU - Hegishi, Hideo

AU - Mizutani, Tatsuaki

AU - Takaoka, Akinori

AU - Taya, Choji

AU - Taniguchi, Tadatsugu

PY - 2005/4/21

Y1 - 2005/4/21

N2 - Robust type-I interferon (IFN-α/β) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity1-6. It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88 (ref. 7). How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88-IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88-IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)3,4,8-11, is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88-IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B) 3,4,8-12. Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.

AB - Robust type-I interferon (IFN-α/β) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity1-6. It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88 (ref. 7). How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88-IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88-IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)3,4,8-11, is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88-IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B) 3,4,8-12. Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=17844380477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844380477&partnerID=8YFLogxK

U2 - 10.1038/nature03547

DO - 10.1038/nature03547

M3 - Article

VL - 434

SP - 1035

EP - 1040

JO - Nature Cell Biology

JF - Nature Cell Biology

SN - 1465-7392

IS - 7036

ER -